source:[1] Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI - BioSpace (https://www.biospace.com/press-releases/savar ...)[2] Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion - BioSpace (https://www.biospace.com/press-releases/golim ...)[3] GE Vernova (GEV) Stock After Hours on Dec. 12, 2025: Why Shares Slid After the Investor-Day Spike—and What to Watch Next - ts2.tech (https://ts2.tech/en/ge-vernova-gev-stock-afte ...)